A study that compared the expression of S100A1, 2, 3, 4, 5, 6, and S100B in different epithelial lesions in the head and neck found these proteins to be most frequently expressed in craniopharyngeomas and cholesteatomas [75]. Here, S100A1 is linked to cholesteatoma.